Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance
- 1 February 2007
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 7 (2) , 136-144
- https://doi.org/10.1016/s1473-3099(07)70025-7
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and ZimbabweBMJ, 2005
- The WHO ???Roll Back Malaria Project???Drug Safety, 2005
- Dapsone Therapy for Malaria During PregnancyDrug Safety, 2004
- Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Mefloquine pharmacokinetics in pregnant women with acute falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Synergistic embryotoxicity of combination pyrimethamine and folic acid in ratsReproductive Toxicology, 1993
- Toxicity studies with quinine hydrochlorideToxicology, 1989
- Placental and Milk Transfer of Chloroquine in HumansTherapeutic Drug Monitoring, 1988
- Mutagenicity testing of quinine with submammalian and mammalian systemsToxicology, 1983
- Saccharin- or Quinine-Induced Changes in the Rat Pups following Prolonged Ingestion by the DamNeonatology, 1979